Table 3.
Haplotype | Case (%) | Control (%) | p | OR (95% CI) |
---|---|---|---|---|
AA | 241 (30.1) | 399 (32.3) | 0.269 | 0.90 (0.74–1.09) |
AG | 392 (49.0) | 641 (51.8) | 0.176 | 0.88 (0.74–1.06) |
TG | 167 (20.9) | 190 (15.4) | 0.002 | 1.44 (1.15–1.82) |
TA | 0 (0.0) | 6 (0.5) |
Case: patient with HBV-related HCC.
Control: individuals who had never been infected with HBV and in whom all HBV serum markers were negative.